The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: An overview with emphasis on the myeloid neoplasms

Chemico-Biological Interactions

Volumn 184, Issue 1-2, 2010, Pages 16-20

  Vardiman, James W ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Acute leukaemia classification; Lymphoma classification; Myeloid neoplasm classification; WHO; WHO classification

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;

ARTICLE; B LYMPHOCYTE; CANCER GENETICS; CELL FUNCTION; CELL LINEAGE; CELL MATURATION; CLINICAL FEATURE; DIAGNOSTIC VALUE; EOSINOPHILIA; GENETIC DISORDER; HEMATOPOIETIC TISSUE; HUMAN; LYMPHOCYTE DIFFERENTIATION; LYMPHOID TISSUE; LYMPHOMA; MIXED MYELODYSPLASTIC MYELOPROLIFERATIVE DISEASE; MYELOID LEUKEMIA; NATURAL KILLER CELL; T LYMPHOCYTE; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; WORLD HEALTH ORGANIZATION;

HEMATOPOIETIC SYSTEM; HUMANS; LEUKEMIA, MYELOID, ACUTE; LYMPHOID TISSUE; LYMPHOMA; MYELODYSPLASTIC SYNDROMES; MYELODYSPLASTIC-MYELOPROLIFERATIVE DISEASES; MYELOPROLIFERATIVE DISORDERS; WORLD HEALTH ORGANIZATION;

EID: 77950624688     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.10.009     Document Type: Article

References (14)

1. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues 2001, IARC, Lyon. E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (Eds.).
2. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, IARC, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
3. Harris N.L., Jaffe E.S., Stein H., et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994, 84:1361-1392.
4. Jaffe E.S., Harris N.L., Stein H., Isaacson P.G. Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood 2008, 112:4384-4399.
5. Vardiman J.W., Thiele J., Arber D.A., et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009, 114:937-951.
6. Hochhaus A., O'Brien S.G., Guilhot F., et al. Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Leukemia 2009, 23:1054-1061.
7. Cuneo A., Ferrant A., Michaux J.L., et al. Cytogenetic and clinicobiological features of acute leukemia with stem cell phenotype: study of nine cases. Cancer Genet. Cytogenet. 1996, 92:31-36.
8. Borowitz M.J., Bene M.-C., Harris N.L., Porwit A., Matutes E. Acute leukemia of ambiguous lineage. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, IARC, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
9. Lorsbach R.B., Shay-Seymore D., Moore J., et al. Clinicopathologic analysis of follicular lymphoma occurring in children. Blood 2002, 99:1959-1964.
10. Oyama T., Ichimura K., Suzuki R., et al. Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am. J. Surg. Pathol. 2003, 27:16-26.
11. Deangelis L.M., Hormigo A. Treatment of primary central nervous system lymphoma. Semin. Oncol. 2004, 31:684-692.
12. Willemze R., Jaffe E.S., Burg G., et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005, 105:3768-3785.
13. Marti G., Abbasi F., Raveche E., et al. Overview of monoclonal B-cell lymphocytosis. Br. J. Haematol. 2007, 139:701-708.
14. Singh Z.N., Huo D., Anastasi J., et al. Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant. Am. J. Clin. Pathol. 2007, 127:197-205.